Riskpilot← Back to searchSign inGet full accessCicek Medical AB
ABActiveOrg 5592640071Hästvägen 21Medical specialists activities · NACE 8622Est. 20201 employees
Revenue 2025
SEK 1,1M
+46% vs 2024
EBITDA margin
10.1%
+70% vs 2024
Equity ratio
28.6%
Financial strength
Net profit 2025
SEK 86K
+68% vs 2024
| Revenue | SEK 1,1M | +46% |
| EBITDA | SEK 113K | +70% |
| Net profit | SEK 86K | +68% |
| Total assets | SEK 405K | +24% |
| Equity | SEK 116K | +45% |
| Employees | 1 | — |
Legal name
Cicek Medical AB
Org number
5592640071
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 juli 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska hyra ut läkare till öron-,näs- och halskliniker. Det handlar primärt om mottagningsverksamhet men jourverksamhet kommer också att vara aktuellt.
Address
Hästvägen 21
Email
taceddincicek@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 204 | 120 | 286 | 764 | 1 116 |
| Staff expenses | — | — | — | −620 | −718 |
| EBITDA | 184 | 102 | 205 | 66 | 113 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 184 | 102 | 311 | 66 | 113 |
| Net financials | — | — | 0 | 1 | −0 |
| Profit before tax | 184 | 102 | 311 | 67 | 112 |
| Tax | −39 | −21 | −64 | −16 | −26 |
| Net profit | 145 | 81 | 247 | 51 | 86 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 255 | 190 | 444 | 326 | 405 |
| Equity | 170 | 142 | 272 | 80 | 116 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 86 | 48 | 171 | 246 | 289 |
| Total debt | 86 | 48 | 171 | 246 | 289 |
EBITDA margin
10.1%
This company
15.8%
Market median
-36% vs market
20212025
Equity ratio
28.6%
This company
38.2%
Market median
-25% vs market
20212025
Return on equity
74.5%
This company
18.4%
Market median
+305% vs market
20212025
Net profit margin
7.7%
This company
8.1%
Market median
-5% vs market
20212025
Asset turnover
2.76×
This company
1.12×
Market median
+146% vs market
20212025
Debt / equity
2.50×
This company
0.62×
Market median
-303% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-01-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cicek Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Taceddin Cicek | Chief Executive Officer | 0 companies |
| Personuppgift Skyddad | Deputy Board Member | 0 companies |